Heading Health is on a mission to accelerate mental well-being through connection-based care. Our co-founder, Steve Levine MD, has designed an outcomes-led approach pairing clinician know-how with a new class of psychotherapy-assisted treatments that offer 3X better outcomes than second-line SSRI’s. These already FDA-approved treatments are Spravato, Transcranial Magnetic Stimulation (TMS), and ketamine, with psychedelic-assisted therapies (MDMA, psilocybin) likely to be approved over the coming years.